I. Why New Coupling Reagents Still Deserve Attention
The development of coupling reagents is not a solved problem. The classic 2011 Chemical Reviews article by El-Faham and Albericio, Peptide Coupling Reagents, More than a Letter Soup, together with the 2018 review on peptide coupling reagent selection, both show that the value of a coupling reagent has never been determined solely by “which one is more reactive.” Rather, the goal is to achieve a better balance among reaction efficiency, control of side reactions, substrate scope, and practical operability.
There are three main reasons why new coupling reagents still need to be developed today.
1. Chirality-related problems have not disappeared.
For reactions involving amino acid derivatives, peptide fragment coupling, and other α-chiral carboxylic acids, racemization or epimerization remains a central issue. A 2024 review on ynamide coupling reagents explicitly pointed out that one of the key advantages of these new reagents is their improved ability to suppress racemization/epimerization, making them suitable for more complex tasks such as peptide fragment coupling and head-to-tail cyclization.
2. Safety issues should not be considered only at the stage of process scale-up.
The choice of a coupling reagent is not only a matter of reaction efficiency; it should also be viewed through the lens of safety-oriented design. A 2018 study systematically evaluated the thermal behavior of 45 commonly used peptide coupling reagents, comparing their thermal stability by methods such as DSC and ARC, and further screening several reagents for potential impact sensitivity or explosion risk.
A 2022 study on the occupational health risks of peptide couplers further showed that the risks associated with these reagents are not limited to thermal safety. Among the 25 commonly used reagents evaluated, 21 tested positive for skin sensitization, and additional risks related to skin corrosion/irritation and eye irritation were also observed. In other words, when discussing whether a coupling reagent is “worth using” today, it is no longer sufficient to consider only whether it can accelerate a reaction or improve yield; one must also take into account process safety, exposure control, and the overall risk profile under real conditions of use.
3. Peptide synthesis is increasingly being driven by green chemistry requirements.
A 2019 article on the sustainability of peptide synthesis and purification summarized the sustainability challenges facing this field. A 2020 review from an industrial perspective further made it clear that current improvement efforts are focused on solvent replacement, recycling and reduction, as well as the exploration of synthetic approaches better suited to large-scale production.
When these three points are considered together, it becomes easier to understand what kinds of new coupling reagents are truly worth attention today. The most valuable new reagents are not simply those that are “more powerful,” but rather those that are more likely to address, at the same time, practical issues related to chirality retention, safety, and process optimization.
Questions more commonly prioritized in the past | More complete evaluation questions today |
How fast is the reaction, and how high is the yield? | Does it simultaneously suppress racemization/epimerization? |
Can the substrate be converted at all? | Is it equally applicable to sterically hindered substrates, peptide fragments, and drug-molecule modification? |
Are the reaction conditions mature? | Are thermal stability, occupational exposure, and process safety acceptable? |
Can it form an amide bond? | Can it also be extended to esterification, solid-phase peptide synthesis, or even other bond-forming tasks? |
Is it supported by classic literature? | Does it also take into account green solvents, recyclability, and the real burden of the overall workflow? |
II. What Roy et al. Reported in the Journal of Organic Chemistry in 2025
The 2025 paper by Roy, Rahaman, Sarkar, and Mandal in the Journal of Organic Chemistry is entitled “Sulfonate Derivative of HOAt (CTSOAt) as a Coupling Reagent for the Construction of C–N, C–O, and C–C Bonds.” It was published in 2025 in Volume 90, Issue 34, pages 12061–12079, with DOI: 10.1021/acs.joc.5c00736. The core content of this paper can be summarized as follows:
What can be confirmed from the published abstract | Straightforward interpretation |
CTSOAt is a new recyclable coupling reagent | This work incorporates recovery and reuse into the design goals of the reagent |
It activates carboxylic acids through the formation of acyl-OAt intermediates | The focus is not merely on being “more reactive,” but on providing a clearly defined mode of activation |
It can be used for the synthesis of amides, esters, and peptides | This indicates that it is a coupling reagent aimed at C–N and C–O bond formation |
It can be used in Pd-catalyzed cross-coupling to prepare ketones from carboxylic acids | This shows that the same mode of carboxylic acid activation can also be extended to C–C bond formation |
It affords good yields, excellent chirality retention, and significant suppression of racemization/epimerization | One major focus of the work is minimizing loss of stereochemical integrity |
It is compatible with solid-phase peptide synthesis | The authors did not stop at small-molecule models in solution-phase chemistry |
The full name of CTSOAt is 3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl 5-chlorothiophene-2-sulfonate. As the name indicates, it is a sulfonate-type coupling reagent derived from HOAt. It activates carboxylic acids through the formation of acyl-OAt intermediates, which then enable the construction of amide, ester, and peptide bonds. In another application line, the paper also shows that it can participate in Pd-catalyzed cross-coupling, enabling the transformation of carboxylic acids into ketones.
III. The Three Most Noteworthy Aspects of This CTSOAt Study
1. It places “chirality retention” at the center
The most noteworthy aspect of the CTSOAt paper is its emphasis in the abstract on excellent chirality retention and significant suppression of racemization/epimerization. Such wording shows that the authors did not focus only on whether the reagent delivered “good yields” or a “broad substrate scope,” but instead explicitly identified preserving the original stereochemical information as much as possible during bond formation as a core outcome. For reactions involving amino acid derivatives, peptide fragment coupling, and other α-chiral carboxylic acids, this point is of greater practical significance than simply emphasizing activation ability.
This is also consistent with the recent development direction of new coupling reagents. A 2024 review on ynamide coupling reagents clearly pointed out that the advantage of these reagents in suppressing racemization/epimerization allows them to be used more effectively in peptide fragment condensation and head-to-tail cyclization. When CTSOAt is viewed in this context, it becomes easier to understand why it deserves to be regarded as a representative study of a broader design direction.
2. It does not stop at solution-phase model reactions
In many new methodology papers, the easiest results to present publicly are usually a set of solution-phase small-molecule model reactions. However, the abstract of the CTSOAt paper directly states its compatibility with solid-phase peptide synthesis. This information is important because it shows that the authors were concerned not only with whether the reagent “works in an ideal model system,” but also with pushing it toward problems that are genuinely relevant to peptide synthesis.
The abstract also provides a highly representative result: in the synthesis of KLVFF under 10% DMSO/ethyl acetate conditions, CTSOAt gave a 56% yield, whereas HATU gave 27% under the same conditions. This result alone is not sufficient to support the conclusion that “CTSOAt is already comprehensively superior to HATU,” but it does show that the study did not confine its demonstrations to solution-phase small-molecule models. At the very least, CTSOAt was advanced to the level of SPPS compatibility and comparison on a specific peptide sequence.
3. It extends its use from amide and ester synthesis to ketone synthesis
The study by Roy and co-workers also provides a third important message: CTSOAt can be used in Pd-catalyzed cross-coupling. CTSOAt first converts the carboxylic acid into an activated form suitable for subsequent reaction, and then under Pd-catalyzed conditions participates in cross-coupling to ultimately give a ketone, thereby enabling the use of carboxylic acids in ketone synthesis. The significance of this result is that CTSOAt is no longer merely a coupling reagent serving amide and ester formation, but becomes a carboxylic acid activation method that can further enter C–C bond construction.
IV. Practical Implications of the CTSOAt Case for Experimental and Research Reagent Selection
Experimental scenario | Questions that deserve higher priority | Practical insight provided by the CTSOAt case |
Amidation or peptide fragment coupling involving α-chiral carboxylic acids | Is racemization or epimerization likely to occur? | Chirality retention should be treated as a priority evaluation criterion, rather than something added only after the reaction has already been shown to work |
Sterically hindered substrates or late-stage modification of complex molecules | Does the reagent perform well only on simple model substrates? | The real value of a reagent should be judged by its performance on complex substrates and genuine research tasks, not only by model reaction results |
Solid-phase peptide synthesis | Can it enter systems that are closer to real peptide synthesis conditions? | It is not enough to look only at solution-phase small-molecule model reactions; one must also examine whether the reagent has real applicability in solid-phase settings and peptide assembly |
Methodological expansion | Can it be extended from C–N/C–O bond formation to other bond-forming applications? | The design of a coupling reagent does not necessarily serve amidation alone; it can also be extended to broader carboxylic acid activation and subsequent bond-forming uses |
Pre-scale-up evaluation | Thermal stability, occupational exposure, recyclability, workup, and the overall process burden | “High reactivity” cannot substitute for safety and sustainability assessment; reagent selection should also simultaneously consider thermal risk, exposure control, and process complexity |
V. References
[1] Roy, S.; Rahaman, S. R.; Sarkar, A.; Mandal, B. Sulfonate Derivative of HOAt (CTSOAt) as a Coupling Reagent for the Construction of C–N, C–O, and C–C Bonds. Journal of Organic Chemistry, 2025, 90(34), 12061–12079. DOI: 10.1021/acs.joc.5c00736.
[2] El-Faham, A.; Albericio, F. Peptide Coupling Reagents, More than a Letter Soup. Chemical Reviews, 2011, 111(11), 6557–6602. DOI: 10.1021/cr100048w.
[3] Albericio, F.; El-Faham, A. Choosing the Right Coupling Reagent for Peptides: A Twenty-Five-Year Journey. Organic Process Research & Development, 2018, 22(7), 760–772. DOI: 10.1021/acs.oprd.8b00159.
[4] Sperry, J. B.; Minteer, C. J.; Tao, J.; Johnson, R.; Duzguner, R.; Hawksworth, M.; Oke, S.; Richardson, P. F.; Barnhart, R.; Bill, D. R.; Giusto, R. A.; Weaver, J. D. III. Thermal Stability Assessment of Peptide Coupling Reagents Commonly Used in Pharmaceutical Manufacturing. Organic Process Research & Development, 2018, 22(9), 1262–1275. DOI: 10.1021/acs.oprd.8b00193.
[5] Graham, J. C.; Trejo-Martin, A.; Chilton, M. L.; Kostal, J.; Bercu, J.; Beutner, G. L.; Bruen, U. S.; Dolan, D. G.; Gomez, S.; Hillegass, J.; Nicolette, J.; Schmitz, M. An Evaluation of the Occupational Health Hazards of Peptide Couplers. Chemical Research in Toxicology, 2022, 35(6), 1011–1022. DOI: 10.1021/acs.chemrestox.2c00031.
[6] Isidro-Llobet, A.; Kenworthy, M. N.; Mukherjee, S.; Kopach, M. E.; Wegner, K.; Gallou, F.; Smith, A. G.; Roschangar, F. Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production. Journal of Organic Chemistry, 2019, 84(8), 4615–4628. DOI: 10.1021/acs.joc.8b03001.
[7] Martin, V.; Egelund, P. H. G.; Johansson, H.; Thordal Le Quement, S.; Wojcik, F.; Sejer Pedersen, D. Greening the Synthesis of Peptide Therapeutics: An Industrial Perspective. RSC Advances, 2020, 10, 42457–42492. DOI: 10.1039/D0RA07204D.
[8] Hu, L.; Zhao, J. Ynamide Coupling Reagents: Origin and Advances. Accounts of Chemical Research, 2024, 57(6), 855–869. DOI: 10.1021/acs.accounts.3c00743.
Table Linking the Core Arguments in the Article to the References
Core argument in the article | Main supporting references |
The evaluation of modern coupling reagents increasingly goes beyond reactivity and yield alone, and now also focuses on racemization control, safety, occupational health, and sustainability. | 2, 4, 5, 6, 7, 8 |
CTSOAt is a new recyclable coupling reagent reported by Roy et al. in the Journal of Organic Chemistry in 2025 | 1 |
CTSOAt activates carboxylic acids through acyl-OAt intermediates and can be used for the synthesis of amides, esters, and peptides | 1 |
CTSOAt can also be used in Pd-catalyzed cross-coupling to prepare ketones from carboxylic acids | 1 |
One of the key highlights of CTSOAt is its good chirality retention and suppression of racemization/epimerization | 1, 8 |
CTSOAt does not stop at solution-phase model reactions, but also enters problems relevant to solid-phase peptide synthesis | 1 |
When choosing a coupling reagent, thermal stability and occupational health risks are also factors that should be considered in advance | 4, 5 |
Green peptide synthesis emphasizes solvent replacement, recycling, and reduction, which also changes the way new reagents are evaluated | 6, 7 |
VI. Reagent Selection Guide Centered on the Design Logic of CTSOAt (Tables 1–3)
Current research or experimental goal | Which table to consult first | Why this table should be consulted first | Which table to consult next | Guidance note |
To first establish a basic benchmark system for classical carboxylic acid activation and amidation/peptide coupling | Table 1 | Table 1 focuses on fundamental systems such as HOAt, HOBt, Oxyma, NHS, and DCC, DIC, EDC, and EEDQ, and is the most suitable place to first understand the routes of “carbodiimide + additive” or “classical coupling reagent” systems | Table 2 | For this type of starting task, it is best to first build a baseline comparison with Table 1, and then use Table 2 to compare whether modern high-activity one-component reagents truly provide improvement. |
To study racemization/epimerization control and compare how different systems affect chirality retention | Table 1 | Table 1 contains HOAt, HOBt, Oxyma, and DIC/EDC/DCC together, making it the most suitable for basic comparisons of “how activation efficiency and racemization control change when the additive changes” | Tables 2 and 3 | If the experimental focus is “low racemization,” it is clearer to first use Table 1 to establish separated-component systems, and then examine COMU, HOTU, and TOTU in Table 2, as well as DEPBT in Table 3. |
To screen conditions for difficult amidation, sterically hindered substrate coupling, or late-stage amidation of complex molecules | Table 2 | Table 2 concentrates on modern high-activity systems such as HATU, HBTU, HCTU, COMU, HOTU, TOTU, TBTU, TSTU, and TCFH/TFFH, making it the most suitable for primary screening in difficult couplings | Table 3 | These tasks usually begin with Table 2; if the results from Table 2 are only moderate, then Table 3 can be consulted for phosphonium salts or nonclassical activation systems as alternative routes. |
To compare CTSOAt with mainstream modern coupling reagents in the context of this article | Table 2 | The main discussion points for CTSOAt are efficient activation, chirality retention, and applicability to peptide coupling, so the most direct comparison targets are usually modern uronium systems such as HATU, COMU, HOTU, and TOTU | Tables 1 and 3 | To make the comparison more complete, Table 1 can provide the baseline of “traditional carbodiimide + additive” systems, while Table 3 can add references based on phosphonium salts or nonclassical activation methods. |
To carry out solid-phase peptide synthesis (SPPS) or fragment coupling and compare different coupling reagent routes | Table 2 | Mainstream selection guides list HBTU, HATU, HCTU, BOP, and PyBOP as common reagents for SPPS or difficult coupling; the abstract of the CTSOAt paper also emphasizes compatibility with solid-phase peptide synthesis | Tables 1 and 3 | For a more systematic SPPS study, one should first examine the modern high-activity reagents in Table 2, then supplement with DIC/additive systems in Table 1, and finally consult alternative routes such as PyAOP, PyBOP, and DMTMM in Table 3. |
To compare how different leaving-group families affect reaction outcomes, such as Bt, OAt, Oxyma, and NHS | Table 2 | Bt-type, OAt-type, Oxyma-type, and NHS-type uronium reagents are most concentrated in Table 2, making it the best place for side-by-side comparison of the effects of changing the leaving group | Table 1 | HOAt, HOBt, Oxyma, and NHS in Table 1 help the reader first understand these leaving groups as independent additives, and then return to Table 2 to examine their performance once embedded into one-component reagents. |
To try routes not fully dependent on uronium systems and look for different carboxylic acid activation logics | Table 3 | Table 3 focuses on phosphonium salts, CDI, DEPBT, DMTMM, and other nonclassical or alternative activation systems, making it the most suitable place to look for complementary solutions “outside uronium systems” | Table 1 | These tasks usually arise when conventional HATU/HBTU/COMU systems are unsatisfactory, or when the researcher wishes to compare different activated-intermediate pathways. |
To discuss greener processes, lower workflow burden, or alternatives to DMF/SPPS conditions | Table 1 | The separated-component systems in Table 1, such as DIC + Oxyma / HOAt / HOBt, are more suitable for analyzing the three variables of additive, carbodiimide, and solvent conditions independently | Tables 2 and 3 | The literature on green peptide synthesis emphasizes solvent replacement, recycling, and reduction; therefore, such tasks should not focus only on high-activity reagents at the outset, but should begin with fundamental systems and variable deconvolution, and then compare the modern reagents in Tables 2 and 3. |
To explore how carboxylic acid activation can be extended to broader reaction applications rather than stopping at amidation | Table 3 | Table 3 better helps the reader understand that “there is more than one route to carboxylic acid activation,” and is well suited to connect with broader activation modes such as CDI and DMTMM | Table 2 | The abstract of the CTSOAt paper shows that its applications are not limited to amides and peptides, but can also enter Pd-catalyzed transformations from carboxylic acids to ketones; therefore, this type of research is better approached by first examining different activation logics and then returning to Table 2 for comparison with modern coupling reagents. |
Table 1. Activation Additives, Active Ester Components, and Classical Foundational Coupling Systems
Category | CAS No. | Aladdin Catalog No. | Name | Grade or Purity | Product Features and Applications |
OAt-type activation additive / anti-racemization additive | 39968-33-7 | 1-Hydroxy-7-azabenzotriazole | ≥99% | A classical OAt-type activation additive, often used together with DIC, EDC, and related reagents to promote carboxylic acid activation and reduce racemization; as an OAt-related system like CTSOAt, it is suitable for comparison of “activation involving an OAt leaving group.” | |
Oxyma-type activation additive / anti-racemization additive | 3849-21-6 | Ethyl (hydroxyimino)cyanoacetate | ≥98% | An Oxyma-related activation additive, commonly combined with DIC or EDC to balance activation efficiency and racemization control; like CTSOAt, it belongs to a newer design approach that emphasizes low racemization performance. | |
NHS active ester additive | 6066-82-6 | N-Hydroxysuccinimide (NHS) | ≥98% | A classical active ester additive that can be used to construct NHS esters for stepwise coupling or bioconjugation; suitable for comparison with the one-step carboxylic acid activation strategy of CTSOAt. | |
Bt-type activation additive / anti-racemization additive | 80029-43-2 | 1-Hydroxybenzotriazole Monohydrate | ≥97%(T) | A classical Bt-type activation additive, commonly used with DCC, DIC, and EDC to suppress side reactions and racemization; suitable for comparison of system evolution alongside HOAt, Oxyma, and CTSOAt. | |
Carbodiimide coupling reagent | 538-75-0 | N,N′-Dicyclohexylcarbodiimide | ≥99% | A classical dehydrative coupling reagent, often used together with HOBt, HOAt, Oxyma, and related additives; suitable for comparison with CTSOAt in terms of by-product burden, workup convenience, and racemization control. | |
Carbodiimide coupling reagent | 693-13-0 | N,N'-Diisopropylcarbodiimide | ≥98.5% | A mainstream carbodiimide reagent for solution-phase and solid-phase use, often combined with Oxyma, HOBt, or HOAt; suitable for comparing “separated-component activation systems” with one-component coupling reagents such as CTSOAt. | |
Water-soluble carbodiimide coupling reagent | 25952-53-8 | N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride | ≥98% | A water-soluble carbodiimide commonly used in aqueous or mixed-solvent coupling and in the preparation of NHS active esters; helpful for benchmarking the positioning of CTSOAt in organic-phase amidation and peptide coupling. | |
Quinoline-type coupling reagent | 16357-59-8 | 2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline | ≥99% | A classical non-uronium coupling reagent that can be used for mild coupling of carboxylic acids with amines; suitable as a historical reference in the framework of “traditional coupling reagents vs. new reagents designed to balance multiple objectives.” |
Table 2. Modern Uronium-Type Coupling Reagents and Halogenated Formamidinium-Type Activation Reagents
Category | CAS No. | Aladdin Catalog No. | Name | Grade or Purity | Product Features and Applications |
OAt-type uronium coupling reagent | 148893-10-1 | HATU | ≥99% | A highly active OAt-type uronium reagent, commonly used in difficult amidation and peptide coupling; as with CTSOAt, it is an important comparison target emphasizing efficient activation and chirality retention. | |
Bt-type uronium coupling reagent | 94790-37-1 | HBTU | ≥99% | A commonly used Bt-type uronium coupling reagent, suitable for routine peptide coupling and amidation; useful for comparing the differences among Bt-, OAt-, and CTSOAt-based systems in activation efficiency and side-reaction control. | |
Chloro-Bt-type uronium coupling reagent | 330645-87-9 | O-(6-Chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate | ≥98% | A chloro-Bt-type uronium reagent, often used in more difficult peptide coupling; suitable for building a “uronium reagent gradient” comparison together with HBTU, HATU, and CTSOAt. | |
Oxyma-type uronium coupling reagent | 1075198-30-9 | COMU | ≥98% | A modern Oxyma-type uronium reagent, often used for amide/peptide coupling that balances activation efficiency, workup convenience, and low racemization; like CTSOAt, it belongs to the “high efficiency + low side reaction” route. | |
Oxyma-type uronium coupling reagent | 333717-40-1 | O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N',N'-tetramethyluronium hexafluorophosphate | ≥98% | An Oxyma-type uronium coupling reagent suitable for studies focused on low racemization and peptide coupling efficiency; can be compared with CTSOAt to examine how different leaving-group systems affect chirality retention and coupling performance. | |
Oxyma-type uronium coupling reagent | 136849-72-4 | TOTU | ≥98% | An alternative Oxyma-type uronium reagent, often used in comparison with HOBt/Bt-type reagents; suitable for studying how changes in counterion and leaving group affect coupling efficiency, workup, and side reactions. | |
Bt-type uronium coupling reagent | 125700-67-6 | TBTU | ≥98% | A classical Bt-type uronium reagent and a common choice in peptide synthesis; suitable for comparing the overall performance of different activation systems together with HBTU, HATU, and CTSOAt. | |
NHS-type uronium coupling reagent / active esterification reagent | 105832-38-0 | O-(N-Succinimidyl)-N,N,N',N'-tetramethyluronium Tetrafluoroborate (TSTU) | ≥97% | An NHS-type uronium reagent suitable for converting carboxylic acids into active esters for subsequent coupling; suitable for experimental comparison with the direct activation-coupling strategy of CTSOAt. | |
Halogenated formamidinium-type activation reagent / precursor of coupling reagents | 94790-35-9 | N,N,N',N'-Tetramethylchloroformamidinium hexafluorophosphate | ≥98% | A highly reactive halogenated formamidinium reagent, also commonly used as a precursor for preparing other coupling reagents; suitable for studying how different carboxylic acid activation modes affect amidation efficiency and side reactions. | |
Halogenated formamidinium-type activation reagent | 164298-23-1 | Fluoro-N,N,N′,N′-tetramethylformamidinium hexafluorophosphate | ≥98% | A highly reactive halogenated formamidinium reagent that can efficiently activate carboxylic acids and is often used in difficult couplings; suitable for comparison with CTSOAt in terms of how different activated-intermediate pathways influence reaction outcomes. |
Table 3. Phosphonium Salt Coupling Reagents and Other Nonclassical Carboxylic Acid Activation Systems
Category | CAS No. | Aladdin Catalog No. | Name | Grade or Purity | Product Features and Applications |
Bt-type phosphonium coupling reagent | 128625-52-5 | 1H-Benzotriazol-1-yloxytripyrrolidinophosphonium Hexafluorophosphate | ≥98% | A classical Bt-type phosphonium coupling reagent, commonly used in peptide synthesis and difficult amidation reactions; suitable for comparing phosphonium-type and new recyclable coupling-reagent strategies alongside HATU, PyAOP, and CTSOAt. | |
Bt-type phosphonium coupling reagent | 56602-33-6 | BOP Reagent | ≥98% | A classical Bt-type phosphonium coupling reagent and one of the representative reagents in the history of peptide coupling; suitable as an experimental reference for “early high-activity coupling reagents.” | |
OAt-type phosphonium coupling reagent | 156311-83-0 | (7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate | ≥97% | An OAt-type phosphonium reagent commonly used in more difficult peptide coupling and fragment condensation; can be compared with HATU, PyBOP, and CTSOAt to evaluate differences in efficiency and chirality retention among OAt-related high-activity systems. | |
Oxyma-type phosphonium coupling reagent | 153433-21-7 | PyOxim | ≥98% | An Oxyma-type phosphonium coupling reagent commonly used in peptide synthesis and more difficult amidation; like CTSOAt, it is suitable for evaluating the balance between activation efficiency and racemization control. | |
Imidazole-type carboxylic acid activation reagent | 530-62-1 | N,N'-Carbonyldiimidazole (CDI) | ≥99% | Activates carboxylic acids through acyl imidazole intermediates and is commonly used in amidation, esterification, and other carbonyl transformations; suitable as a comparison route that is neither uronium-type nor carbodiimide-type. | |
Benzotriazinone-type low-racemization coupling reagent | 165534-43-0 | 3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one | ≥98% | A coupling reagent often highlighted for relatively low racemization and good peptide-coupling selectivity; suitable as an important reference for CTSOAt in the context of “chirality-retention-oriented” design. | |
Triazine-type coupling/activation reagent | 3945-69-5 | 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMTMM) | ≥97% | A triazine-type carboxylic acid activation reagent that can be used in both solution-phase and solid-phase peptide synthesis; suitable as a comparison route outside benzotriazole and OAt chemistry for evaluating the scope of different activation modes. |
Note: The above are representative Aladdin products. For more product specifications, please refer to the product list at the end of the article or search the Aladdin website using the product name/CAS/catalog number.
For more related articles, see below: